Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin versus cisplatin induction chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma
ChiCTR-TRC-13003285Phase 3Completed
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Apr 2013
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lobaplatin, cisplatin and fluorouracil in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Progression-free survival. Started Apr 2013; status: completed.
02
Drugs
lobaplatincisplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-TRC-13003285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003285.